Sanofi Active Ingredient Solutions

Sanofi CEPiA

Within the Industrial Affairs of Sanofi, CEPiA is an organization fully dedicated to third party activities.

One of the key activities of CEPiA is to offer a broad range of innovative solutions including:

  • Supply of Active Pharmaceutical Ingredients (APIs) and Intermediates
  • Custom Synthesis & API Contract Manufacturing
  • Pharma Contract Manufacturing

CEPiA Sales is a Sanofi activity dedicated to manufacturing and supply of a broad range of APIs available on a catalogue basis.

By employing its exhaustive industrial capabilities, facilities and expertise expected of large pharma, CEPiA provides its clients with «fast to market» solutions.

We offer API Contract Manufacturing & Custom Synthesis competences from small molecules to biologics, from lab scale to commercial quantities. Additionaly, we offer our extensive drug product facilities.

To handle complex industrial projects, CEPiA relies on the wide Sanofi Industrial network.
Roughly 16 Chemical & Biotech sites located in 6 countries (mainly in Europe) manufacture intermediates and APIs for third party projects.
About 38 pharmaceutical sites located in 25 countries worlwide offer their production capacities for third party market.
In total, more than 50 Sanofi sites are in support of CEPiA activity.

Chemistry and Biotechnologies expertise:

Pharma Technologies:

  • Injectables
  • Non injectables
  • Solids & semi-solids


Pharmaceutical Technologies:

  • Sterile:
    • Injectable
      • Pre-filled syringes, Freeze-dying of ampoules and vials, Bio Products filling, etc.
    • Non Injectable
      • Drops, Aerosols and Sprayx, Tubes, etc.
  • Non Sterile:
    • Solids and Semi-Solids
      • Granulation and coating, multi-layer tablets, tab in tab, etc.
  • Segregated Workshops:
    • Penicillins, Cephalosporins, High Potent Actives, Cytotoxics

Copyright © Kymanox, All Rights Reserved.